Literature DB >> 3025634

Active X chromosome DNA is unmethylated at eight CCGG sites clustered in a guanine-plus-cytosine-rich island at the 5' end of the gene for phosphoglycerate kinase.

D H Keith, J Singer-Sam, A D Riggs.   

Abstract

The 5' control region and first exon for human X-chromosome-linked phosphoglycerate kinase is contained in a G + C-rich island. We measured methylation at all HpaII sites in this 5' region of leukocyte DNA. By use of a blotting procedure that allows analysis of small DNA fragments, we found that the HpaII sites are entirely methylated when from an inactive X chromosome and entirely unmethylated when from an active one. In contrast, methylation of HpaII sites in more downstream regions of the gene is essentially the same in active and inactive X chromosomes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025634      PMCID: PMC367182          DOI: 10.1128/mcb.6.11.4122-4125.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  19 in total

1.  Identification of a nondeletion defect in alpha-thalassemia.

Authors:  Y W Kan; A M Dozy; R Trecartin; D Todd
Journal:  N Engl J Med       Date:  1977-11-17       Impact factor: 91.245

2.  Methylation of the PGK promoter region and an enhancer way-station model for X-chromosome inactivation.

Authors:  A D Riggs; J Singer-Sam; D H Keith
Journal:  Prog Clin Biol Res       Date:  1985

3.  Differences in methylation on the active and inactive human X chromosomes.

Authors:  S Lindsay; M Monk; R Holliday; L Huschtscha; K E Davies; A D Riggs; R A Flavell
Journal:  Ann Hum Genet       Date:  1985-05       Impact factor: 1.670

4.  Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinase.

Authors:  J Singer-Sam; D H Keith; K Tani; R L Simmer; L Shively; S Lindsay; A Yoshida; A D Riggs
Journal:  Gene       Date:  1984-12       Impact factor: 3.688

5.  Studies of X chromosome DNA methylation in normal human cells.

Authors:  S F Wolf; B R Migeon
Journal:  Nature       Date:  1982-02-25       Impact factor: 49.962

6.  Promoter sequences of eukaryotic protein-coding genes.

Authors:  J Corden; B Wasylyk; A Buchwalder; P Sassone-Corsi; C Kedinger; P Chambon
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

Review 7.  DNA methylation and gene function.

Authors:  A Razin; A D Riggs
Journal:  Science       Date:  1980-11-07       Impact factor: 47.728

8.  The human phosphoglycerate kinase multigene family. HLA-associated sequences and an X-linked locus containing a processed pseudogene and its functional counterpart.

Authors:  A M Michelson; G A Bruns; C C Morton; S H Orkin
Journal:  J Biol Chem       Date:  1985-06-10       Impact factor: 5.157

9.  Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: implications for X-chromosome inactivation.

Authors:  S F Wolf; D J Jolly; K D Lunnen; T Friedmann; B R Migeon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

10.  Complete concordance between glucose-6-phosphate dehydrogenase activity and hypomethylation of 3' CpG clusters: implications for X chromosome dosage compensation.

Authors:  S F Wolf; S Dintzis; D Toniolo; G Persico; K D Lunnen; J Axelman; B R Migeon
Journal:  Nucleic Acids Res       Date:  1984-12-21       Impact factor: 16.971

View more
  50 in total

1.  X inactivation as a mechanism of selection against lethal alleles: further investigation of incontinentia pigmenti and X linked lymphoproliferative disease.

Authors:  A Harris; J Collins; D Vetrie; C Cole; M Bobrow
Journal:  J Med Genet       Date:  1992-09       Impact factor: 6.318

2.  Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability.

Authors:  G P Pfeifer; S D Steigerwald; R S Hansen; S M Gartler; A D Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

3.  Hypermethylation of human DNA sequences in embryonal carcinoma cells and somatic tissues but not in sperm.

Authors:  X Y Zhang; P T Loflin; C W Gehrke; P A Andrews; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

4.  Differential methylation of the ornithine carbamoyl transferase gene on active and inactive mouse X chromosomes.

Authors:  L J Mullins; G Veres; C T Caskey; V Chapman
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

5.  Localization of the translocation breakpoint in a female with Menkes syndrome to Xq13.2-q13.3 proximal to PGK-1.

Authors:  V Verga; B K Hall; S R Wang; S Johnson; J V Higgins; T W Glover
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

6.  Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation.

Authors:  J Singer-Sam; M Grant; J M LeBon; K Okuyama; V Chapman; M Monk; A D Riggs
Journal:  Mol Cell Biol       Date:  1990-09       Impact factor: 4.272

7.  Different patterns of X inactivation in MZ twins discordant for red-green color-vision deficiency.

Authors:  A L Jørgensen; J Philip; W H Raskind; M Matsushita; B Christensen; V Dreyer; A G Motulsky
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

8.  The mouse Pgk-1 gene promoter contains an upstream activator sequence.

Authors:  M W McBurney; L C Sutherland; C N Adra; B Leclair; M A Rudnicki; K Jardine
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

Review 9.  Genetics of human X-linked immunodeficiency diseases.

Authors:  R W Hendriks; R K Schuurman
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

10.  De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines.

Authors:  P A Jones; M J Wolkowicz; W M Rideout; F A Gonzales; C M Marziasz; G A Coetzee; S J Tapscott
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.